/viestories/media/media_files/2025/02/12/9u88zdaX8Rtn9M84Lgi3.png)
Biocon Share Price Targe
Biocon Limited, founded in 1978 is one of India's largest pharmaceutical companies, focusing on the research and treatment of severe diseases like cancer and diabetes. It ranks 8th in India pharma sector with a market capitalization of ₹32,794 crore. Biocon’s share price, currently at ₹277.10 INR, is a key factor in its reputation and growth. The company regularly predicts its share price for the coming years with future predictions such as Biocon Share Price Prediction 2025 and Biocon Share Price Prediction 2030, based on market conditions.
/viestories/media/media_files/2025/02/03/6xUSNufI4vmd02Dk19Tx.jpg)
Each year, the company sets targets, like the Biocon Share Price Target 2024 and continues the process for future years with targets set for 2025, 2026, 2027, and beyond.
Table of Contents
Biocon Limited Share price Target 2025 :-
Biocon Limited Share Price Target 2025: Biocon’s stock is expected to stay stable in 2025, with a target range from ₹361.27 in January to ₹358.68 in December, showing minimal fluctuations throughout the year.
| Months | Target Price |
| January | 361.27 |
| February | 366.48 |
| March | 361.22 |
| April | 358.65 |
| May | 358.67 |
| June | 358.69 |
| July | 358.72 |
| August | 358.72 |
| September | 358.74 |
| October | 358.75 |
| November | 358.7 |
| December | 358.68 |
Know more about the best traders in India.
Biocon Limited Share price Target 2026 :-
Biocon Limited Share Price Target for 2026 shows a consistent upward trend, with monthly targets ranging from ₹387.29 to ₹395.2, reflecting stable growth and performance expectations for the year.
| Months | Target Price |
| January | 389.96 |
| February | 395.2 |
| March | 390.01 |
| April | 387.41 |
| May | 387.38 |
| June | 387.41 |
| July | 387.37 |
| August | 387.34 |
| September | 387.29 |
| October | 387.33 |
| November | 387.34 |
| December | 387.38 |
Biocon Limited Share price Target 2027:-
Biocon Limited Share Price Target for 2027 shows steady growth, with monthly targets ranging from ₹417.12 to ₹425.36, indicating a stable outlook for the year.
| Months | Target Price |
| January | 420.21 |
| February | 425.36 |
| March | 417.12 |
| April | 417.48 |
| May | 417.52 |
| June | 417.52 |
| July | 417.57 |
| August | 417.54 |
| September | 417.51 |
| October | 417.51 |
| November | 417.55 |
| December | 417.51 |
Biocon Limited Share price Target 2028 :-
Biocon Limited Share Price Target for 2028 shows consistent growth, with monthly targets ranging from ₹449.18 to ₹457.04, reflecting a positive trend for the year.
| Months | Target Price |
| January | 451.82 |
| February | 457.04 |
| March | 451.79 |
| April | 449.18 |
| May | 449.17 |
| June | 449.19 |
| July | 449.21 |
| August | 449.24 |
| September | 449.2 |
| October | 449.25 |
| November | 449.28 |
| December | 449.23 |
Biocon Limited Share price Target 2029 :-
Biocon Limited Share Price Target for 2029 indicates steady growth, with monthly targets ranging from ₹482.51 to ₹490.31, showcasing a positive performance outlook.
| Months | Target Price |
| January | 485.14 |
| February | 490.31 |
| March | 485.14 |
| April | 482.51 |
| May | 482.5 |
| June | 482.53 |
| July | 482.53 |
| August | 482.58 |
| September | 482.61 |
| October | 482.61 |
| November | 482.64 |
| December | 482.68 |
Biocon Limited Share price Target 2030 :-
Biocon Limited Share Price Target for 2030 shows a consistent upward trend, with monthly targets ranging from ₹517.40 to ₹525.26, reflecting stable growth potential.
| Months | Target Price |
| January | 520.06 |
| February | 525.26 |
| March | 520.04 |
| April | 517.47 |
| May | 517.43 |
| June | 517.42 |
| July | 517.46 |
| August | 517.45 |
| September | 517.48 |
| October | 517.44 |
| November | 517.4 |
| December | 517.41 |
Biocon Limited Shareholding Pattern:-
| Shareholders | Share Percent |
| Promoters | 60.64 percent |
| Public holding | 39.03 percent |
| Mutual Funds | 5.12 percent |
| FII | 6.55 percent |
| DII | 14.52 percent |
Biocon Limited competitors:-
- EMS Pharma
- Cipla
- Sun Pharma
- Idorsia
- Kedrion
- Clinipace
- Molmed
- Bloomage biotech
- Irvine pharmaceutical service
- Biolog
Conclusion -
Biocon Limited is a global company focused on medical research, particularly for serious diseases like cancer and diabetes. It ranks 8th in the pharmaceutical sector, showing strong performance. The company also does well in the stock market, with its share price rising by 1.7% compared to the previous closing price, ranging between ₹276.15 and ₹278.52. In India, it's seen as a solid investment due to its consistent price growth and potential for profit. Though the company has some debt, it is expected to pay it off in the coming years through its profits. Biocon has many subsidiaries worldwide as part of its multinational presence.
FAQs
Disclaimer:
- The information is based on our understanding of the stock's historical performance.
- Stock market predictions are unpredictable and can change, so expert advice is strongly recommended before investing.
- The values provided are based on predictions and may not be accurate, we recommend verifying the information with other sources.
- For further inquiries about the stock market, please contact us via email.
